Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | B3gnt2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of B3GNT2 mRNA] | CTD | PMID:31150632 | B3gnt2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of B3GNT2 mRNA | CTD | PMID:36331819 | B3gnt2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of B3GNT2 mRNA | CTD | PMID:22206623 | B3gnt2 | Rat | 17beta-estradiol | affects expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Estradiol affects the expression of B3GNT2 mRNA | CTD | PMID:22574217 | B3gnt2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of B3GNT2 mRNA | CTD | PMID:29581250 | B3gnt2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | affects expression | ISO | B3gnt2 (Mus musculus) | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of B3GNT2 mRNA | CTD | PMID:24680724 | B3gnt2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | B3gnt2 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of B3GNT2 mRNA | CTD | PMID:24680724 | B3gnt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of B3GNT2 mRNA | CTD | PMID:19770486 | B3gnt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of B3GNT2 mRNA | CTD | PMID:33387578 | B3gnt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of B3GNT2 mRNA | CTD | PMID:32109520|PMID:34747641 | B3gnt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression more ... | CTD | PMID:25975270 | B3gnt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GNT2 mRNA | CTD | PMID:21570461|PMID:24680724 | B3gnt2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of B3GNT2 mRNA | CTD | PMID:21346803 | B3gnt2 | Rat | 2-butoxyethanol | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of B3GNT2 mRNA | CTD | PMID:19812364 | B3gnt2 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of B3GNT2 mRNA | CTD | PMID:30851411 | B3gnt2 | Rat | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of B3GNT2 mRNA | CTD | PMID:27914987 | B3gnt2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | B3gnt2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | B3gnt2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of B3GNT2 mRNA | CTD | PMID:28973697 | B3gnt2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of B3GNT2 mRNA | CTD | PMID:24780913 | B3gnt2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of B3GNT2 mRNA | CTD | PMID:30047161 | B3gnt2 | Rat | afimoxifene | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | afimoxifene results in increased expression of B3GNT2 mRNA | CTD | PMID:16849584 | B3gnt2 | Rat | all-trans-retinoic acid | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of B3GNT2 mRNA | CTD | PMID:16788091 | B3gnt2 | Rat | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of B3GNT2 mRNA | CTD | PMID:20488242 | B3gnt2 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of B3GNT2 mRNA | CTD | PMID:35163327 | B3gnt2 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of B3GNT2 mRNA | CTD | PMID:30047161 | B3gnt2 | Rat | arsenite(3-) | affects expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | arsenite affects the expression of B3GNT2 mRNA | CTD | PMID:22959463 | B3gnt2 | Rat | benzo[a]pyrene | affects methylation | ISO | B3GNT2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of B3GNT2 5' UTR | CTD | PMID:27901495 | B3gnt2 | Rat | bis(2-ethylhexyl) phthalate | affects methylation | ISO | B3gnt2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate affects the methylation of B3GNT2 gene | CTD | PMID:38833407 | B3gnt2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of B3GNT2 mRNA | CTD | PMID:25181051 | B3gnt2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | B3gnt2 | Rat | bisphenol A | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of B3GNT2 mRNA | CTD | PMID:29275510 | B3gnt2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of B3GNT2 gene | CTD | PMID:28505145 | B3gnt2 | Rat | bisphenol F | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | B3gnt2 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | B3gnt2 | Rat | bortezomib | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of B3GNT2 mRNA | CTD | PMID:20977926 | B3gnt2 | Rat | Butylbenzyl phthalate | increases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of B3GNT2 mRNA | CTD | PMID:28392331 | B3gnt2 | Rat | cadmium atom | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of B3GNT2 more ... | CTD | PMID:37236586 | B3gnt2 | Rat | cadmium dichloride | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of B3GNT2 more ... | CTD | PMID:37236586 | B3gnt2 | Rat | calcitriol | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of B3GNT2 mRNA | CTD | PMID:21592394 | B3gnt2 | Rat | calcitriol | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GNT2 mRNA | CTD | PMID:21592394 | B3gnt2 | Rat | CGP 52608 | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to B3GNT2 gene] | CTD | PMID:28238834 | B3gnt2 | Rat | chlordecone | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of B3GNT2 mRNA | CTD | PMID:33711761 | B3gnt2 | Rat | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of B3GNT2 mRNA | CTD | PMID:23125180 | B3gnt2 | Rat | choline | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | B3gnt2 | Rat | cisplatin | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of B3GNT2 mRNA | CTD | PMID:27594783 | B3gnt2 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of B3GNT2 mRNA | CTD | PMID:24386269 | B3gnt2 | Rat | copper(II) chloride | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of B3GNT2 mRNA | CTD | PMID:38568856 | B3gnt2 | Rat | copper(II) sulfate | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of B3GNT2 mRNA | CTD | PMID:19549813 | B3gnt2 | Rat | cyclosporin A | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of B3GNT2 mRNA | CTD | PMID:25562108|PMID:27989131 | B3gnt2 | Rat | dexamethasone | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | B3gnt2 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of B3GNT2 mRNA | CTD | PMID:21266533 | B3gnt2 | Rat | dibutyl phthalate | increases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of B3GNT2 mRNA | CTD | PMID:21266533 | B3gnt2 | Rat | dorsomorphin | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | B3gnt2 | Rat | doxorubicin | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of B3GNT2 mRNA | CTD | PMID:29803840 | B3gnt2 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of B3GNT2 mRNA | CTD | PMID:24136188 | B3gnt2 | Rat | folic acid | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | B3gnt2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of B3GNT2 mRNA | CTD | PMID:22061828 | B3gnt2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of B3GNT2 mRNA | CTD | PMID:33387578 | B3gnt2 | Rat | glyphosate | affects methylation | ISO | B3GNT2 (Homo sapiens) | 6480464 | Glyphosate affects the methylation of B3GNT2 gene | CTD | PMID:35377194 | B3gnt2 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of B3GNT2 mRNA | CTD | PMID:21396975 | B3gnt2 | Rat | indometacin | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | B3gnt2 | Rat | keratan sulfate | increases chemical synthesis | ISO | B3GNT2 (Homo sapiens) | 6480464 | B3GNT2 protein results in increased chemical synthesis of Keratan Sulfate | CTD | PMID:12218059 | B3gnt2 | Rat | L-methionine | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | B3gnt2 | Rat | lead(0) | decreases methylation | ISO | B3gnt2 (Mus musculus) | 6480464 | Lead results in decreased methylation of B3GNT2 gene | CTD | PMID:38833407 | B3gnt2 | Rat | melphalan | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Melphalan results in increased expression of B3GNT2 mRNA | CTD | PMID:22363485 | B3gnt2 | Rat | methidathion | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | methidathion results in decreased expression of B3GNT2 mRNA | CTD | PMID:34813904 | B3gnt2 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of B3GNT2 mRNA | CTD | PMID:30047161 | B3gnt2 | Rat | methylmercury chloride | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of B3GNT2 mRNA | CTD | PMID:23179753|PMID:27188386 | B3gnt2 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of B3GNT2 mRNA | CTD | PMID:24810058 | B3gnt2 | Rat | ochratoxin A | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of B3GNT2 mRNA | CTD | PMID:22124623 | B3gnt2 | Rat | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of B3GNT2 mRNA | CTD | PMID:22124623 | B3gnt2 | Rat | okadaic acid | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of B3GNT2 mRNA | CTD | PMID:38832940 | B3gnt2 | Rat | paracetamol | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of B3GNT2 mRNA | CTD | PMID:21420995 | B3gnt2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of B3GNT2 mRNA | CTD | PMID:33387578 | B3gnt2 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of B3GNT2 mRNA | CTD | PMID:37995155 | B3gnt2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | B3gnt2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of B3GNT2 mRNA | CTD | PMID:36331819 | B3gnt2 | Rat | pirinixic acid | decreases expression | ISO | B3gnt2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of B3GNT2 mRNA | CTD | PMID:23811191 | B3gnt2 | Rat | rac-lactic acid | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of B3GNT2 mRNA | CTD | PMID:30851411 | B3gnt2 | Rat | SB 431542 | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | B3gnt2 | Rat | sodium arsenite | affects methylation | ISO | B3GNT2 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of B3GNT2 gene | CTD | PMID:28589171 | B3gnt2 | Rat | sodium arsenite | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of B3GNT2 mRNA | CTD | PMID:39719251 | B3gnt2 | Rat | sodium arsenite | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of B3GNT2 mRNA | CTD | PMID:38568856 | B3gnt2 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of B3GNT2 mRNA | CTD | PMID:30047161 | B3gnt2 | Rat | sunitinib | decreases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of B3GNT2 mRNA | CTD | PMID:31533062 | B3gnt2 | Rat | testosterone | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GNT2 mRNA | CTD | PMID:21592394 | B3gnt2 | Rat | testosterone | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of B3GNT2 mRNA | CTD | PMID:21592394 | B3gnt2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of B3GNT2 mRNA | CTD | PMID:31150632 | B3gnt2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of B3GNT2 mRNA] | CTD | PMID:31150632 | B3gnt2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of B3GNT2 mRNA | CTD | PMID:34492290 | B3gnt2 | Rat | thiram | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Thiram results in increased expression of B3GNT2 mRNA | CTD | PMID:38568856 | B3gnt2 | Rat | titanium dioxide | decreases methylation | ISO | B3gnt2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of B3GNT2 promoter | CTD | PMID:35295148 | B3gnt2 | Rat | titanium dioxide | increases methylation | ISO | B3gnt2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of B3GNT2 gene | CTD | PMID:35295148 | B3gnt2 | Rat | trichostatin A | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of B3GNT2 mRNA | CTD | PMID:26272509 | B3gnt2 | Rat | trichostatin A | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | B3gnt2 | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of B3GNT2 mRNA | CTD | PMID:30589522 | B3gnt2 | Rat | urethane | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Urethane results in increased expression of B3GNT2 mRNA | CTD | PMID:28818685 | B3gnt2 | Rat | valproic acid | increases expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of B3GNT2 mRNA | CTD | PMID:23179753 | B3gnt2 | Rat | valproic acid | affects expression | ISO | B3GNT2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of B3GNT2 mRNA | CTD | PMID:25979313 | B3gnt2 | Rat | zinc atom | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of B3GNT2 mRNA | CTD | PMID:18593933 | B3gnt2 | Rat | zinc(0) | multiple interactions | ISO | B3GNT2 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of B3GNT2 mRNA | CTD | PMID:18593933 | |






















